Hunter Smith - Chief Financial Officer at Rhythm Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Hunter Smith - trading volume in the past year for Rhythm Pharmaceuticals, Inc.

Holdings reported by Hunter Smith for Rhythm Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 97,939 $3.84 M $39.22 Mar 19, 2024 Direct
Restricted Stock Units 26,400 $1.32 M $50.01 Feb 16, 2024 Direct Common Stock
Stock Option (Right to Buy) 80,400 Feb 16, 2024 Direct Common Stock

Transactions reported by Hunter Smith for Rhythm Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership